Biological medicine archivos

Biological medicine MBK-01 News

Mikrobiomik has obtained approval for EUTEGRA (MBK-01) as the first gut microbiota-based biological therapy authorised in Spain

Mikrobiomik has obtained approval for EUTEGRA (MBK-01) as the first gut microbiota-based biological therapy authorised…

elen9miKK17/02/2026

Biological medicine MBK-01 Microbiota News

MBK-01 demonstrates its clinical impact against Clostridioides difficile infection

A real-life case shows how a microbiota-based therapy can provide an effective alternative when conventional…

elen9miKK07/01/2026

(FMT) Fecal Microbiota Transplantation Articles Articles of interest Biological medicine

Recurrent Diverticulitis: too much main, too few answers

Posted by Carlota Dopico - Business Development & Innovation Manager - 23/07/2025 Diverticulitis is an…

elen9miKK23/07/2025

Biological medicine Clostridium Difficile Microbiota News

We have launched a €500,000 round on Capital Cell

10/07/2025 We have launched a €500,000 round on Capital Cell to launch the first oral…

elen9miKK10/07/2025

Contador de células microbianas QUANTOM TXTM

Biological medicine News

A new validation that brings excellence to Mikrobiomik and to the pharmaceutical industry

09/09/24 As a disruptive and pioneering company, Mikrobiomik has achieved a significant milestone by introducing…

elen9miKK09/09/2024

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necesary

Always Enabled

Functional

Analytics

Others

Perfomance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Cookie	Duration	Description
YSC	session	This cookies is set by Youtube and is used to track the views of embedded videos.

Biological medicine5

Mikrobiomik has obtained approval for EUTEGRA (MBK-01) as the first gut microbiota-based biological therapy authorised in Spain

MBK-01 demonstrates its clinical impact against Clostridioides difficile infection

Recurrent Diverticulitis: too much main, too few answers

We have launched a €500,000 round on Capital Cell

A new validation that brings excellence to Mikrobiomik and to the pharmaceutical industry

Do you want to know more about Mikrobiomik?

Contact us

Address

Contact